Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling

Saved in:
Bibliographic Details
Published in:3 Biotech
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301678297907201
collection WordPress RSS
FRELIP Feed Integration
container_title 3 Biotech
description
discipline_display Biotechnology
discipline_facet Biotechnology
format Online Article
RSS Article
genre Journal Article
id rss_article:80979
institution FRELIP
journal_source_facet 3 Biotech
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling
Biotechnology
General
Biotechnology
sub_discipline_display General
sub_discipline_facet General
subject_display Biotechnology
General
Biotechnology
Biotechnology
General
Biotechnology
subject_facet Biotechnology
General
Biotechnology
title Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling
title_auth Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling
title_full Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling
title_fullStr Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling
title_full_unstemmed Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling
title_short Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling
title_sort alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of dpp-4 activity and opg/rankl signaling
topic Biotechnology
General
Biotechnology
url https://link.springer.com/article/10.1007/s13205-026-04889-7